0,830  0,004  Caspase 3 stimulant
0,792  0,005  CYP1A2 substrate
0,787  0,013  Caspase 9 stimulant
0,773  0,011  Antineoplastic (lung cancer)
0,773  0,020  Apoptosis agonist
0,754  0,005  Antineoplastic (non-small cell lung cancer)
0,734  0,004  Cardiodepressant
0,721  0,006  5 Hydroxytryptamine release stimulant
0,708  0,006  Antineoplastic (melanoma)
0,711  0,012  CYP2C9 substrate
0,671  0,008  CYP2D6 substrate
0,663  0,005  Antineoplastic (multiple myeloma)
0,663  0,005  Antineoplastic (brain cancer)
0,661  0,004  Genotoxic
0,663  0,013  Respiratory analeptic
0,644  0,004  Anesthetic general
0,637  0,019  15-Lipoxygenase inhibitor
0,634  0,030  Antineoplastic (breast cancer)
0,612  0,008  CYP2C19 inhibitor
0,617  0,014  Sensitization
0,599  0,005  Tubulin antagonist
0,613  0,022  Antileukemic
0,613  0,028  CYP3A4 substrate
0,591  0,006  Antineoplastic (glioblastoma multiforme)
0,594  0,011  NOS2 expression inhibitor
0,592  0,009  Antineoplastic (glioma)
0,596  0,018  Prostate cancer treatment
0,568  0,007  Psychostimulant
0,559  0,005  Muscle relaxant
0,557  0,006  Antineoplastic (renal cancer)
0,572  0,035  Transcription factor NF kappa B inhibitor
0,545  0,008  Antineoplastic (lymphoma)
0,561  0,027  Antineoplastic (colorectal cancer)
0,559  0,026  Antineoplastic (colon cancer)
0,534  0,009  CYP3A4 inhibitor
0,527  0,013  Antipyretic
0,507  0,008  Antineoplastic (carcinoma)
0,503  0,005  Breast cancer-resistant protein inhibitor
0,500  0,012  Antimitotic
0,505  0,019  Chemopreventive
0,512  0,025  Antineoplastic (ovarian cancer)
0,505  0,022  Radioprotector
0,490  0,007  Hepatoprotectant
0,479  0,005  Skeletal muscle relaxant
0,494  0,023  Hepatic disorders treatment
0,493  0,023  Analeptic
0,480  0,014  Antihypertriglyceridemic
0,478  0,018  CYP1A2 inhibitor
0,484  0,025  Spasmolytic
0,474  0,025  12-Lipoxygenase inhibitor
0,449  0,009  Antineoplastic (squamous cell carcinoma)
0,470  0,030  Antihypercholesterolemic
0,452  0,014  Sedative
0,452  0,023  Vasodilator, coronary
0,454  0,026  Antioxidant
0,451  0,027  Carcinogenic
0,432  0,010  Antiseptic
0,445  0,027  Lipoxygenase inhibitor
0,410  0,004  Alpha tubulin antagonist
0,417  0,014  P-glycoprotein inhibitor
0,408  0,006  Carcinogenic, group 2B
0,418  0,019  Sigma receptor agonist
0,406  0,011  Melanin inhibitor
0,411  0,017  Antineoplastic (lymphocytic leukemia)
0,423  0,033  Antineoplastic (pancreatic cancer)
0,416  0,026  Free radical scavenger
0,413  0,024  Nitric oxide antagonist
0,442  0,054  Histamine release inhibitor
0,414  0,028  UGT2B4 substrate
0,390  0,006  Neurotrophic factor enhancer
0,429  0,045  Angiogenesis inhibitor
0,446  0,062  TNF expression inhibitor
0,415  0,034  Antineoplastic (cervical cancer)
0,388  0,009  Liver fibrosis treatment
0,397  0,024  Antineoplastic (liver cancer)
0,407  0,034  CYP2D6 inhibitor
0,408  0,054  CYP2C9 inhibitor
0,386  0,033  Antiprotozoal (Leishmania)
0,357  0,006  Carcinogenic, group 1
0,364  0,022  Abortion inducer
0,451  0,110  Antiinflammatory
0,369  0,033  Tumour necrosis factor alpha release inhibitor
0,358  0,031  Vasodilator
0,338  0,021  Antimutagenic
0,332  0,023  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,329  0,021  Skin irritative effect
0,415  0,108  Alpha-glucosidase inhibitor
0,355  0,049  CYP2C19 substrate
0,334  0,039  Mutagenic
0,339  0,044  DNA damaging
0,301  0,010  CDC-like kinase 1 inhibitor
0,296  0,006  Cyclooxygenase 3 inhibitor
0,290  0,004  CDC-like kinase 3 inhibitor
0,332  0,051  Hypoxia-inducible factor 1 alpha inhibitor
0,327  0,050  Antineoplastic (small cell lung cancer)
0,390  0,113  Transcription factor inhibitor
0,337  0,062  AR expression inhibitor
0,299  0,026  VCAM1 expression inhibitor
0,295  0,025  Male reproductive disfunction treatment
0,277  0,008  UGT2B10 substrate
0,313  0,044  Pyruvate kinase inhibitor
0,336  0,069  FMO1 substrate
0,346  0,088  GST A substrate
0,291  0,036  5 Hydroxytryptamine 1E antagonist
0,268  0,014  Topoisomerase I inhibitor
0,273  0,021  Topoisomerase II inhibitor
0,302  0,051  Cytostatic
0,295  0,047  5 Hydroxytryptamine uptake stimulant
0,271  0,025  Anesthetic
0,247  0,005  Inducible nitric-oxide synthase inhibitor
0,304  0,063  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,245  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,242  0,005  Carcinogenic, group 2A
0,239  0,003  Endothelin receptor antagonist
0,240  0,004  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,362  0,130  Antineoplastic (solid tumors)
0,248  0,022  LDLR expression enhancer
0,247  0,021  Acetylcholinesterase inhibitor
0,241  0,016  Alpha 2b adrenoreceptor antagonist
0,284  0,060  GST M1-1 substrate
0,308  0,086  Cholesterol antagonist
0,255  0,035  CYP2B6 inhibitor
0,248  0,028  Carcinogenic, group 3
0,320  0,103  Immunosuppressant
0,231  0,014  Microtubule formation inhibitor
0,232  0,017  Butyrylcholinesterase inhibitor
0,312  0,097  Prostaglandin dehydrogenase inhibitor
0,241  0,028  Skin whitener
0,274  0,062  Proliferative diseases treatment
0,218  0,007  Beta tubulin antagonist
0,229  0,022  Antifungal enhancer
0,234  0,028  Erectile dysfunction treatment
0,214  0,009  Vanilloid 1 agonist
0,229  0,025  Anesthetic local
0,228  0,024  MAO A inhibitor
0,255  0,053  Clk dual-specificity kinase inhibitor
0,211  0,016  Alpha 2c adrenoreceptor antagonist
0,204  0,012  Adenylate cyclase stimulant
0,226  0,034  MAO inhibitor
0,196  0,005  Phosphodiesterase 11A inhibitor
0,196  0,005  Phosphodiesterase XI inhibitor
0,286  0,095  Apoptosis antagonist
0,205  0,017  Alpha 2 adrenoreceptor antagonist
0,214  0,026  Phobic disorders treatment
0,223  0,036  Amylase inhibitor
0,192  0,008  CYP2A6 inhibitor
0,242  0,059  Antiparkinsonian, rigidity relieving
0,213  0,031  Antineoplastic (bone cancer)
0,190  0,010  Transcription factor NF kappa B stimulant
0,233  0,054  UGT1A1 substrate
0,179  0,003  Endothelin B receptor antagonist
0,179  0,004  Endothelin A receptor antagonist
0,206  0,032  Cyclooxygenase 1 inhibitor
0,326  0,151  DNA polymerase beta inhibitor
0,226  0,053  Pneumotoxic
0,184  0,013  Nitric-oxide synthase inhibitor
0,188  0,017  Topoisomerase II alpha inhibitor
0,279  0,108  Vasodilator, peripheral
0,297  0,126  Antiprotozoal
0,180  0,010  DOPA decarboxylase inhibitor
0,187  0,017  Antineoplastic alkaloid
0,176  0,008  Vanilloid agonist
0,274  0,107  Antithrombotic
0,231  0,068  Antiulcerative
0,232  0,070  Antihypotensive
0,220  0,057  Non-steroidal antiinflammatory agent
0,266  0,104  Bone diseases treatment
0,203  0,041  UGT2B15 substrate
0,168  0,008  Phosphodiesterase V inhibitor
0,254  0,095  Antihypoxic
0,241  0,082  Hypoglycemic
0,208  0,050  5 Hydroxytryptamine 3E antagonist
0,272  0,117  Antineoplastic (endocrine cancer)
0,172  0,017  Calcium antagonist
0,176  0,022  Alcohol dehydrogenase substrate
0,220  0,068  Amyloid beta aggregation inhibitor
0,251  0,100  FMO3 substrate
0,199  0,048  Acaricide
0,262  0,113  Antiallergic
0,158  0,010  Phosphodiesterase 5A inhibitor
0,165  0,019  Phosphodiesterase IV inhibitor
0,193  0,050  Cholinergic
0,146  0,005  Endocannabinoid uptake inhibitor
0,187  0,047  Uterine stimulant
0,166  0,026  Choleretic
0,149  0,010  Prostaglandin EP2 antagonist
0,188  0,049  ATPase inhibitor
0,300  0,161  DNA directed DNA polymerase inhibitor
0,163  0,025  Heat shock protein 70 antagonist
0,152  0,014  UGT2B11 substrate
0,183  0,048  NOS3 expression enhancer
0,185  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,261  0,129  Antiprotozoal (Plasmodium)
0,141  0,009  GABA aminotransferase inhibitor
0,135  0,004  Exportin-1 inhibitor
0,180  0,051  UGT2B9 substrate
0,214  0,085  Embryotoxic
0,169  0,047  Phosphodiesterase inhibitor
0,195  0,074  Platelet adhesion inhibitor
0,222  0,101  Antiprotozoal (Trypanosoma)
0,156  0,036  Interleukin 1b antagonist
0,209  0,090  Teratogen
0,124  0,005  Potassium channel Kv1.3 blocker
0,173  0,054  Lipid peroxidase inhibitor
0,176  0,058  Protein-tyrosine phosphatase inhibitor
0,180  0,067  Tumour necrosis factor antagonist
0,199  0,087  Antiparasitic
0,149  0,037  MAO B inhibitor
0,155  0,045  Epidermal growth factor receptor kinase inhibitor
0,175  0,065  UGT1A3 substrate
0,220  0,111  Chemoprotective
0,257  0,148  GABA C receptor rho-3 antagonist
0,190  0,082  Cytotoxic
0,154  0,046  Monophenol monooxygenase inhibitor
0,130  0,024  Phosphodiesterase 4D inhibitor
0,150  0,045  Protein-tyrosine phosphatase 1B inhibitor
0,123  0,020  Glutamate decarboxylase inhibitor
0,214  0,113  Tyrosine 3 hydroxylase inhibitor
0,104  0,004  Ryanodine receptor antagonist
0,121  0,024  Phosphodiesterase 6D inhibitor
0,107  0,009  Leukotriene B4 antagonist
0,173  0,076  Succinate dehydrogenase inhibitor
0,127  0,033  Antiviral (Coronavirus)
0,127  0,033  Antiviral (SARS coronavirus)
0,184  0,091  Insulin sensitizer
0,195  0,101  Dyrk kinase inhibitor
0,116  0,023  ATPase (Vacuolar H+) inhibitor
0,141  0,050  Antitussive
0,096  0,005  Adenylate cyclase 1 inhibitor
0,142  0,051  Antiviral (Hepatitis B)
0,149  0,060  Neurotrophic factor
0,091  0,005  Factor III inhibitor
0,114  0,029  Restless leg syndrome treatment
0,102  0,019  Phosphodiesterase VI inhibitor
0,125  0,043  GST P1-1 substrate
0,098  0,017  Antitreponemal
0,128  0,047  Mucolytic
0,125  0,047  Expectorant
0,191  0,114  Cardiovascular analeptic
0,166  0,089  CDC-like kinase 4 inhibitor
0,102  0,026  Lipase inhibitor
0,203  0,128  Cardioprotectant
0,166  0,091  Wound healing agent
0,126  0,052  TRPA1 agonist
0,137  0,064  NADPH oxidase inhibitor
0,199  0,127  Antineoplastic (sarcoma)
0,180  0,108  Antineoplastic enhancer
0,148  0,077  Cytidine deaminase inhibitor
0,155  0,084  UGT2B7 substrate
0,139  0,069  Bone formation stimulant
0,147  0,078  Heat shock protein 90 antagonist
0,147  0,078  GABA C receptor rho-2 antagonist
0,121  0,053  Sphingosine 1-phosphate receptor 2 agonist
0,209  0,141  Antifungal
0,187  0,120  RNA-directed DNA polymerase inhibitor
0,220  0,153  Antineoplastic (osteosarcoma)
0,117  0,051  Electron transport complex I inhibitor
0,218  0,152  ICAM1 expression inhibitor
0,110  0,045  Estrogen receptor beta antagonist
0,093  0,028  Calcium channel L-type blocker
0,100  0,036  Antiviral (Hepatitis A)
0,127  0,064  Antiviral (Papilloma)
0,155  0,093  3C-like protease (Human coronavirus) inhibitor
0,084  0,023  Glutamate (mGluR7) antagonist
0,144  0,084  Eye irritation, high
0,121  0,061  Antifungal (Pneumocystis)
0,103  0,043  Alpha 2d adrenoreceptor antagonist
0,193  0,134  DNA synthesis inhibitor
0,117  0,060  Estrogen antagonist
0,109  0,053  Antihypermotility
0,100  0,044  Ornithine decarboxylase inhibitor
0,080  0,024  Alpha 2 adrenoreceptor agonist
0,122  0,067  Antiprotozoal (Amoeba)
0,104  0,050  Posttraumatic stress disorder treatment
0,186  0,133  Superoxide dismutase inhibitor
0,108  0,055  Bronchodilator
0,087  0,034  Alpha adrenoreceptor agonist
0,189  0,136  Antiosteoporotic
0,063  0,011  Squalene synthetase inhibitor
0,160  0,109  DNA methylase inhibitor
0,171  0,120  Aryl hydrocarbon receptor agonist
0,238  0,189  Antibacterial
0,107  0,058  5-Lipoxygenase inhibitor
0,224  0,179  Calcium channel activator
0,101  0,056  Alpha adrenoreceptor antagonist
0,150  0,106  Phospholipase C inhibitor
0,084  0,042  Estrogen receptor alpha antagonist
0,134  0,093  Antiviral (Herpes)
0,054  0,012  Diamine oxidase inhibitor
0,127  0,086  Hair growth stimulant
0,085  0,045  Nicotinic alpha4beta2 receptor antagonist
0,074  0,033  Beta adrenoreceptor antagonist
0,137  0,096  UGT1A4 substrate
0,076  0,035  Leukotriene antagonist
0,051  0,012  Vesicle monoamine transporter inhibitor
0,080  0,042  Histidine decarboxylase inhibitor
0,091  0,053  Tocolytic
0,060  0,023  Anesthetic inhalation
0,047  0,011  Melatonin agonist
0,148  0,112  Antihelmintic
0,077  0,042  5 Hydroxytryptamine 1A antagonist
0,203  0,168  CTGF expression inhibitor
0,064  0,030  Postmenopausal disorders treatment
0,097  0,063  Sphingomyelinase inhibitor
0,158  0,124  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,045  0,012  Melatonin 1 agonist
0,140  0,107  Myocardial ischemia treatment
0,102  0,070  Antifungal (Aspergillus)
0,044  0,013  Melatonin 2 agonist
0,036  0,005  Imidazoline I1 receptor antagonist
0,079  0,049  Narcotic antagonist
0,096  0,068  Anabolic
0,038  0,010  Dopamine autoreceptor agonist
0,040  0,012  Leukotriene B4 receptor 1 antagonist
0,123  0,096  Cyclooxygenase inhibitor
0,050  0,023  Phosphodiesterase 6C inhibitor
0,090  0,063  Antiadrenergic
0,087  0,062  Adrenaline antagonist
0,063  0,039  Aromatase inhibitor
0,197  0,175  Thioredoxin glutathione reductase inhibitor
0,146  0,124  I kappa B kinase epsilon inhibitor
0,050  0,029  Carnitine palmitoyltransferase 1B inhibitor
0,171  0,150  Lipoprotein disorders treatment
0,130  0,110  Interferon gamma antagonist
0,059  0,039  Fibroblast growth factor 4 antagonist
0,156  0,139  Antiamyloidogenic
0,075  0,058  Macrophage migration inhibitory factor inhibitor
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,179  0,164  Antiischemic
0,052  0,037  Vanilloid 2 antagonist
0,080  0,065  Epidermal growth factor antagonist
0,073  0,060  Keratolytic
0,104  0,092  Shock treatment
0,017  0,007  Melatonin receptor 1A antagonist
0,106  0,096  Contraceptive female
0,115  0,104  Antiischemic, cerebral
0,051  0,042  Nicotinic alpha3beta2 receptor antagonist
0,059  0,051  Dopamine D1 antagonist
0,039  0,032  Plasmepsin II inhibitor
0,026  0,019  Nicotinic acid receptor 2 antagonist
0,058  0,051  Nitric oxide donor
0,027  0,021  Thrombin receptor antagonist
0,032  0,026  Melatonin receptor 1A agonist
0,125  0,119  Arachidonic acid antagonist
0,107  0,101  Antiviral (Influenza B)
0,087  0,082  Sulfotransferase substrate
0,036  0,032  GABA uptake inhibitor
0,049  0,046  Alpha-mannosidase inhibitor
0,011  0,008  Imidazoline I2 receptor antagonist
0,105  0,103  Coagulant
0,073  0,071  Opioid kappa receptor antagonist
0,056  0,054  5 Hydroxytryptamine 5A antagonist
0,059  0,058  Beta 3 adrenoreceptor antagonist
0,125  0,124  Antianginal

